Your session is about to expire
← Back to Search
Beet Juice Supplementation for Coronary Artery Disease
Study Summary
This trial looks at whether beet juice can help improve vascular and inspiratory muscle function in older adults with coronary artery disease.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your heart's pumping ability is lower than 50%.You have unstable chest pain.You had a heart attack in the last 6 months.You have had a stroke in the past.You have a lung disease that makes it hard to breathe.You use any form of tobacco, including cigarettes or e-cigarettes.You regularly do aerobic exercise training.You have a history of heart disease based on a test showing more than half narrowing in a major heart blood vessel, a previous heart attack, or a past heart surgery to improve blood flow.You have stable coronary artery disease and are taking the right medications for it.You are between 60 and 85 years old.You have had heart surgery or procedures to open blocked arteries in the past 6 months.You have hepatitis B, hepatitis C, or HIV.You have ongoing or recurring seizures or other serious illnesses.You have had respiratory training in the past year or cardiac rehabilitation in the past 6 months.Your high blood pressure is not well controlled.
- Group 1: Nitrate rich beetroot juice
- Group 2: Nitrate depleted beetroot juice
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are applications for the trial being accepted currently?
"Affirmative, information on clinicaltrials.gov confirms that this experiment is currently taking in applicants. It was first announced on November 12th 2021 and most recently revised on January 14th 2022; the study requires 24 participants to be enrolled at a single facility."
Would I qualify for participation in this trial?
"This medical experiment is enrolling 24 participants aged between 60 and 85, who have been diagnosed with coronary artery disease. Furthermore, potential patients must be either male or post-menopausal female (whether naturally or surgically), and able to provide consent for the trial."
What are the main goals of this research project?
"Primarily, this clinical trial seeks to assess changes in endothelial function over an initial two-week period. Secondary metrics include alterations in central arterial hemodynamics measured with the SphygmoCor XCEL device, functional capacity evaluated via the Duke Activity Status Index, and microvascular functions examined through ultrasound imaging of brachial artery blood flow and diameter during submaximal handgrip exercise."
Does this trial seek participants aged twenty and over?
"This research is seeking participants who are between 60 and 85 years old."
What is the capacity of this clinical experiment?
"That is correct. Clinicaltrials.gov indicates that this particular trial, which was initially posted on November 12th 2021, is open for enrollment of 24 participants within 1 medical centre."
Share this study with friends
Copy Link
Messenger